Solventum Corporation (SOLV)
Healthcare • Medical Instruments & Supplies
StockNYSEUnited StatesUS83444M1018
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Solventum Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 20:18. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 16:00 | 1.77 | — | — | Upcoming |
| 05 Nov 2026 16:00 | 1.34 | 1.45 | +7.9% | Beat |
| 05 Aug 2026 16:00 | 1.91 | 2.55 | +33.8% | Beat |
| 05 May 2026 16:00 | 1.35 | 1.48 | +9.3% | Beat |
| 26 Feb 2026 16:00 | 1.50 | 1.57 | +5.0% | Beat |
| 06 Nov 2025 16:00 | 1.43 | 1.50 | +4.7% | Beat |
| 07 Aug 2025 16:00 | 1.45 | 1.69 | +16.3% | Beat |
| 08 May 2025 16:00 | 1.22 | 1.34 | +9.7% | Beat |
| 27 Feb 2025 16:00 | 1.31 | 1.41 | +7.8% | Beat |
| 07 Nov 2024 16:00 | 1.39 | 1.64 | +17.7% | Beat |
| 08 Aug 2024 16:00 | 1.51 | 1.56 | +3.7% | Beat |
| 09 May 2024 06:00 | 1.75 | 2.08 | +19.2% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 8.3B | +0.9% | 1.6B | 18.7% | 8.88 | +221.7% | -10M |
| 2024 | 8.3B | +0.7% | 479M | 5.8% | 2.76 | -64.6% | 805M |
| 2023 | 8.2B | +0.8% | 1.3B | 16.4% | 7.79 | +0.2% | 1.6B |
| 2022 | 8.1B | — | 1.3B | 16.5% | 7.78 | — | 1.4B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 89.07 | 89.61 | 87.50 | 88.90 | +0.32% | 499,628 | |
| 11 Nov 2026 | 89.30 | 90.26 | 88.46 | 88.62 | -1.62% | 728,300 | |
| 10 Nov 2026 | 89.64 | 90.57 | 87.90 | 90.08 | -0.39% | 1,245,300 | |
| 09 Nov 2026 | 90.99 | 91.62 | 88.46 | 90.43 | +0.06% | 1,291,800 | |
| 06 Nov 2026 | 86.45 | 93.10 | 85.04 | 90.38 | +3.67% | 3,168,900 | |
| 05 Nov 2026 | 90.34 | 90.50 | 85.57 | 87.18 | -2.43% | 1,880,600 | |
| 04 Nov 2026 | 87.49 | 90.61 | 87.48 | 89.35 | +5.42% | 2,168,000 | |
| 03 Nov 2026 | 84.02 | 85.38 | 83.71 | 84.76 | +0.01% | 1,006,200 | |
| 02 Nov 2026 | 82.46 | 84.76 | 81.66 | 84.75 | +4.21% | 1,242,300 | |
| 30 Oct 2026 | 84.15 | 84.48 | 80.76 | 81.33 | -2.67% | 1,067,200 | |
| 652 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- SOLV Q3 2026 deep dive: ERP transition, separation milestones, and margin focus define quarter (opens in a new tab) StockStory · 10 Nov 2026 12:29
- Solventum (SOLV) stock trades up, here is why (opens in a new tab) StockStory · 10 Nov 2026 07:17
- Top Medical Supply Stock Picks From BTIG (opens in a new tab) Investing.com · 09 Nov 2026 16:09
- Solventum Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 08 Nov 2026 23:14
- What Is Solventum (SOLV) Signaling With Its 90% Separation And HIS Split Plan? (opens in a new tab) Simply Wall St. · 07 Nov 2026 02:17
- SOLV Q3 Earnings Beat Estimates Despite ERP-Related Revenues Decline (opens in a new tab) Zacks · 06 Nov 2026 15:02
- Solventum Corp (SOLV) Q3 2026 Earnings Call Highlights: Separation Nears Completion as EPS ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 11:16
- Wells Fargo Maintains Equal-Weight on Solventum, Raises Price Target to $95 (opens in a new tab) Benzinga · 06 Nov 2026 10:50
- Piper Sandler Reiterates Overweight on Solventum, Raises Price Target to $110 (opens in a new tab) Benzinga · 06 Nov 2026 10:27
- Solventum (SOLV) Raises Guidance After Q3 Beat, Is The Stock Still Undervalued? (opens in a new tab) Simply Wall St. · 06 Nov 2026 09:17
- Solventum (SOLV) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 06 Nov 2026 07:31
- Solventum (NYSE:SOLV) Q3 2026 Earnings: In-Line Revenue, EPS Beat, Shares Flat After Hours (opens in a new tab) ChartMill · 06 Nov 2026 00:44
- Solventum (NYSE:SOLV) beats Q3 2026 sales expectations (opens in a new tab) StockStory · 05 Nov 2026 22:47
- S&P 500 After-Hours Movers: ABNB and SNDK Gain, AXON and SOLV Fall (opens in a new tab) ChartMill · 05 Nov 2026 22:06
- Solventum (SOLV) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (opens in a new tab) Zacks · 05 Nov 2026 22:00
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 88.62 USD
- Market cap
- 14.9B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow SOLV and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.